Tuesday, February 11, 2025 11:26:30 AM
Recent CJMB News
- Callan JMB Expands Long-Standing Public Sector Infrastructure Engagement • GlobeNewswire Inc. • 05/20/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/13/2026 05:55:56 PM
- Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC • GlobeNewswire Inc. • 04/17/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 09:00:19 PM
- Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer • GlobeNewswire Inc. • 04/07/2026 12:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 09:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:06:31 PM
- Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/31/2026 08:05:00 PM
- Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement • GlobeNewswire Inc. • 03/27/2026 12:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:01:55 PM
- Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID • GlobeNewswire Inc. • 03/11/2026 12:45:00 PM
- iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 • ACCESS Newswire • 03/04/2026 02:00:00 PM
- Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026 • GlobeNewswire Inc. • 03/02/2026 01:45:00 PM
- Callan JMB Announces Participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10–11, 2026 • GlobeNewswire Inc. • 02/27/2026 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2026 10:10:11 PM
- DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event • ACCESS Newswire • 01/23/2026 07:50:00 PM
- Callan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026 • GlobeNewswire Inc. • 01/20/2026 02:00:00 PM
- Callan JMB Signs Manufacturing Oversight, Federal Deployment, and Commercialization Agreement of Multi-Asset Therapeutic Pipeline with Attune for Approximately $50 to $75 Million in Total Revenue • GlobeNewswire Inc. • 01/15/2026 01:45:00 PM
- Callan JMB Inc. (NASDAQ:CJMB) Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility • ACCESS Newswire • 01/12/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 04:51:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/31/2025 02:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 12:54:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 09:56:36 PM
